Basis: FMP quote price / unrounded FMP forward EPS in the trading currency, available after its recorded retrieval time. Source: stored company filings and market data; unavailable inputs remain N/A.
The forward PE ratio is N/A as of 2026-10-06T19:23:02.447Z.
Consensus retrieved: unavailable. This records retrieval, including cache reads, rather than vendor publication. The calculation uses the separately dated price and estimate available at its as-of time.
Calculation as of: 2026-10-06T19:23:02.447Z.
Quote observation: 2026-10-06T19:20:10.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: f372f39edc86e990c580289f142e0fc1828f45467bffd466be8591b91f734aee
FORWARD PE RATIO
N/A
NOMAD Power Solutions, Inc.
Market Cap
$52.65M
Forward PE Ratio
N/A
| NAME | MARKET CAP | FORWARD PE RATIO |
|---|---|---|
| NOMAD Power Solutions, Inc. (NMAD) | $52.65M | N/A |
| Zhengye Biotechnology Holding Limited (ZYBT)vs › | $52.13M | N/A |
| ImageneBio Inc (IMA)vs › | $53.24M | N/A |
| biote Corp. (BTMD)vs › | $52.05M | N/A |
| Aldeyra The (ALDX)vs › | $53.30M | N/A |
| Spectral AI, Inc. (MDAI)vs › | $53.31M | N/A |
| Rani Therapeutics Holdings, Inc. (RANI)vs › | $53.58M | N/A |
| eXoZymes, Inc. (EXOZ)vs › | $51.51M | N/A |
| Eloxx Pharmaceuticals, Inc. (ELOX)vs › | $51.03M | N/A |
| Clene Inc. (CLNN)vs › | $50.86M | N/A |
Trailing P/E
N/A
reported TTM EPS
Forward P/E
N/A
consensus fiscal-year EPS
PE Ratio = Share Price / Diluted EPS (TTM)
The price-to-earnings ratio measures how much investors pay for each dollar of trailing earnings. A lower PE can indicate a cheaper valuation; a higher PE implies higher growth expectations.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
